IP Library Patent Application 13762843
Patent Application
App. No. 13/762,843

METHODS FOR SEQUENCING NUCLEIC ACID

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/762,843
Abstract

The invention generally relates to methods for sequencing a nucleic acid template from both a 5′ and a 3′ end in a single sequencing reaction. In certain embodiments, methods of the invention involve amplifying a nucleic acid template to produce a plurality of amplicons, splitting the amplicons into first and second portions, attaching a first oligonucleotide including a first universal primer site to a 5′ end of the amplicons in the first portion, and attaching a second oligonucleotide including a second universal primer site to a 3′ end of the amplicons in the second portion. The first and second primer sites may be the same or may be different. The method additionally involves pooling the first and second portions, and sequencing the pooled amplicons, thereby sequencing a nucleic acid template from both a 5′ and a 3′ end in a single sequencing reaction.

Claims (28)

1 . A method for sequencing a nucleic acid template from both a 5′ and a 3′ end in a single sequencing reaction, the method comprising:

amplifying a nucleic acid template to produce a plurality of amplicons;

splitting the amplicons into first and second portions;

attaching a first oligonucleotide comprising a first universal primer site to a 5′ end of the amplicons in the first portion;

attaching a second oligonucleotide comprising a second universal primer site to a 3′ end of the amplicons in the second portion;

pooling the first and second portions; and

sequencing the pooled amplicons, thereby sequencing a nucleic acid template from both a 5′ and a 3′ end in a single sequencing reaction.

2 . The method of claim 1 , wherein amplifying is via a polymerase chain reaction.

3 . The method of claim 1 , wherein the 5′ and 3′ ends of each of the plurality of amplicons comprise an adaptor sequence, wherein the 5′ and the 3′ adaptor are different.

4 . The method of claim 3 , wherein attaching the first oligonucleotide comprises:

providing the first oligonucleotide, the oligonucleotide comprising a first portion that is complementary to the adaptor attached at the 5′ end of the amplicon and a second portion that comprises the first universal primer site; and

conducting an amplification reaction between the amplicons of the first portion and the first oligonucleotides, to thereby produce amplicons comprising the first universal primer site attached to a 5′ end of the amplicons.

5 . The method of claim 4 , wherein amplification is via PCR.

6 . The method of claim 3 , wherein attaching the second oligonucleotide comprises:

providing the second oligonucleotide, the oligonucleotide comprising a first portion that is complementary to the adaptor attached at the 3′ end of the amplicon and a second portion that comprises the second universal primer site; and

conducting an amplification reaction between the amplicons of the second portion and the second oligonucleotides, to thereby produce amplicons comprising the second universal primer site attached to a 3′ end of the amplicons.

7 . The method of claim 6 , wherein amplification is via PCR.

8 . The method of claim 1 , wherein splitting comprises compartmentalizing the amplicons into compartmentalized portions.

9 . The method according to claim 8 , wherein the compartmentalized portions are droplets and compartmentalizing comprises forming the droplets.

10 . The method according to claim 9 , wherein the droplets are aqueous droplets in an immiscible carrier fluid.

11 . The method according to claim 10 , wherein the immiscible carrier fluid is oil.

12 . The method according to claim 11 , wherein the oil comprises a surfactant.

13 . The method according to claim 12 , wherein the surfactant is a fluorosurfactant.

14 . The method according to claim 11 , wherein the oil is a fluorinated oil.

15 . The method according to claim 9 , wherein pooling comprises collecting the droplets in a vessel and releasing the amplicons from the droplets.

16 . The method according to claim 1 , wherein sequencing is sequencing-by-synthesis.

17 . The method according to claim 16 , wherein in sequencing-by-synthesis is single molecule sequencing-by-synthesis.

18 . The method according to claim 1 , wherein the first and second primer sites are different.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CRG ISSUER 2015-1
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 041290/0585 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Sep 17, 2013
From: RAINDANCE TECHNOLOGIES, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031267/0376 →